ORCID as entered in ROS

Select Publications
2022, 'Genetic metabolic disease', in Keeling's Fetal and Neonatal Pathology, pp. 267 - 289, http://dx.doi.org/10.1007/978-3-030-84168-3_l1
,2022, 'Genetic Metabolic Disease', in Keeling's Fetal and Neonatal Pathology, Springer International Publishing, pp. 267 - 289, http://dx.doi.org/10.1007/978-3-030-84168-3_11
,2018, 'Effectiveness of early hematopoietic stem cell transplantation in preventing neurocognitive decline in mucopolysaccharidosis type ii: A case series', in JIMD Reports, pp. 81 - 89, http://dx.doi.org/10.1007/8904_2018_104
,2015, 'Genetic metabolic disease', in Keeling's Fetal and Neonatal Pathology, pp. 275 - 298, http://dx.doi.org/10.1007/978-3-319-19207-9_11
,2014, 'The molecular bases of phenylketonuria (PKU) in new south wales, australia: Mutation profile and correlation with tetrahydrobiopterin (BH
2025, 'Characterizing circulating biomarkers for childhood dementia disorders: A scoping review of clinical trials', Neurotherapeutics, 22, http://dx.doi.org/10.1016/j.neurot.2025.e00546
,2025, ''Fighting every day': Exploring caregiver quality of life and perspectives on healthcare services for children with dementia - A cross-sectional, mixed-methods study', Archives of Disease in Childhood, pp. archdischild-2024-328011, http://dx.doi.org/10.1136/archdischild-2024-328011
,2025, 'The Australian Genomics Mitochondrial Flagship: A national program delivering mitochondrial diagnoses', Genetics in Medicine, 27, http://dx.doi.org/10.1016/j.gim.2024.101271
,2024, 'Psychosocial experiences of clinicians providing care for children with severe neurological impairment', Developmental Medicine and Child Neurology, 66, pp. 1622 - 1631, http://dx.doi.org/10.1111/dmcn.15987
,2024, 'Counting Conditions on Newborn Bloodspot Screening Panels in Australia and New Zealand', International Journal of Neonatal Screening, 10, http://dx.doi.org/10.3390/ijns10030047
,2024, '‘Integrating Ethics and Equity with Economics and Effectiveness for newborn screening in the genomic age: A qualitative study protocol of stakeholder perspectives', PLoS ONE, 19, pp. 1 - 13, http://dx.doi.org/10.1371/journal.pone.0299336
,2023, 'Characterizing Common Phenotypes Across the Childhood Dementia Disorders: A Cross-sectional Study From Two Australian Centers', Pediatric Neurology, 149, pp. 75 - 83, http://dx.doi.org/10.1016/j.pediatrneurol.2023.09.006
,2023, 'The psychosocial impact of childhood dementia on children and their parents: a systematic review', Orphanet Journal of Rare Diseases, 18, http://dx.doi.org/10.1186/s13023-023-02859-3
,2023, 'The Australian landscape of newborn screening in the genomics era', Rare Disease and Orphan Drugs Journal, 2, http://dx.doi.org/10.20517/rdodj.2023.30
,2023, 'Diagnosis and management of children with McArdle Syndrome (GSD V) in New South Wales', JIMD Reports, 64, pp. 327 - 336, http://dx.doi.org/10.1002/jmd2.12389
,2023, 'Exercise testing and prescription in patients with inborn errors of muscle energy metabolism', Journal of Inherited Metabolic Disease, 46, pp. 763 - 777, http://dx.doi.org/10.1002/jimd.12644
,2023, 'Recapitulation of Skewed X-Inactivation in Female Ornithine Transcarbamylase-Deficient Primary Human Hepatocytes in the FRG Mouse: A Novel System for Developing Epigenetic Therapies', Human Gene Therapy, 34, pp. 917 - 926, http://dx.doi.org/10.1089/hum.2023.011
,2023, 'Rapid whole‐genome sequencing leading to specific treatment for two infants with haemophagocytic lymphohistiocytosis due to Wolman disease', Pediatric Blood and Cancer, http://dx.doi.org/10.1002/pbc.30394
,2023, 'Treatment of HMG-CoA Lyase Deficiency—Longitudinal Data on Clinical and Nutritional Management of 10 Australian Cases', Nutrients, 15, pp. 531, http://dx.doi.org/10.3390/nu15030531
,2023, 'STANDARD BIOMARKERS DO NOT CORRELATE WITH DISEASE PROGRESSION IN CHILDHOOD-ONSET COBALAMIN C DISEASE', MOLECULAR GENETICS AND METABOLISM, 138, pp. 87 - 87, http://dx.doi.org/10.1016/j.ymgme.2023.107480
,2022, 'Intronic variants in inborn errors of metabolism: Beyond the exome', Frontiers in Genetics, 13, http://dx.doi.org/10.3389/fgene.2022.1031495
,2022, 'Biallelic pathogenic variants in COX11 are associated with an infantile-onset mitochondrial encephalopathy', Human Mutation, 43, pp. 1970 - 1978, http://dx.doi.org/10.1002/humu.24453
,2022, '3-Methylglutaconyl-CoA hydratase deficiency: When ascertainment bias confounds a biochemical diagnosis', JIMD Reports, 63, pp. 568 - 574, http://dx.doi.org/10.1002/jmd2.12332
,2022, 'A narrative review of metabolomics in the era of “-omics”: integration into clinical practice for inborn errors of metabolism', Translational Pediatrics, 11, pp. 1704 - 1716, http://dx.doi.org/10.21037/tp-22-105
,2022, 'Findings from the Morquio A Registry Study (MARS) after 6 years: Long-term outcomes of MPS IVA patients treated with elosulfase alfa', Molecular Genetics and Metabolism, 137, pp. 164 - 172, http://dx.doi.org/10.1016/j.ymgme.2022.08.007
,2022, 'International Congress of Inborn Errors of Metabolism (ICIEM) Sydney 2021', Journal of Inherited Metabolic Disease, 45, pp. 863, http://dx.doi.org/10.1002/jimd.12539
,2022, 'A serendipitous journey to a promoter variant: The c.-106C>A variant and its role in late-onset ornithine transcarbamylase deficiency', JIMD Reports, 63, pp. 271 - 275, http://dx.doi.org/10.1002/jmd2.12289
,2022, 'FGF21 outperforms GDF15 as a diagnostic biomarker of mitochondrial disease in children', Molecular Genetics and Metabolism, 135, pp. 63 - 71, http://dx.doi.org/10.1016/j.ymgme.2021.12.001
,2021, 'GLRX5-associated [Fe-S] cluster biogenesis disorder: further characterisation of the neurological phenotype and long-term outcome', Orphanet Journal of Rare Diseases, 16, http://dx.doi.org/10.1186/s13023-021-02073-z
,2021, 'Purpuric, delayed child: Beyond septicaemia and into inborn errors of metabolism', Journal of Paediatrics and Child Health, 57, pp. 1703 - 1706, http://dx.doi.org/10.1111/jpc.15365
,2021, 'Liver transplantation in children with inborn errors of metabolism: 30 years experience in NSW, Australia', JIMD Reports, 60, pp. 88 - 95, http://dx.doi.org/10.1002/jmd2.12219
,2021, 'New insights into carnitine-acylcarnitine translocase deficiency from 23 cases: Management challenges and potential therapeutic approaches', Journal of Inherited Metabolic Disease, 44, pp. 903 - 915, http://dx.doi.org/10.1002/jimd.12371
,2021, 'Investigating paediatric hypoglycaemia: Dynamic studies at a tertiary paediatric hospital', Journal of Paediatrics and Child Health, 57, pp. 888 - 893, http://dx.doi.org/10.1111/jpc.15349
,2021, 'Rare diseases research and policy in Australia: On the journey to equitable care', Journal of Paediatrics and Child Health, 57, pp. 778 - 781, http://dx.doi.org/10.1111/jpc.15507
,2021, 'Fatal Perinatal Mitochondrial Cardiac Failure Caused by Recurrent De Novo Duplications in the ATAD3 Locus', Med, 2, pp. 49 - 73.e10, http://dx.doi.org/10.1016/j.medj.2020.06.004
,2021, 'Effectiveness of early hematopoietic stem cell transplantation in preventing neurocognitive decline in aspartylglucosaminuria: A case series', JIMD Reports, 61, pp. 3 - 11, http://dx.doi.org/10.1002/jmd2.12222
,2020, 'Protecting the rare during a rare pandemic', Medical Journal of Australia, 213, pp. 94 - 94.e1, http://dx.doi.org/10.5694/mja2.50671
,2020, 'The diagnostic utility of genome sequencing in a pediatric cohort with suspected mitochondrial disease', Genetics in Medicine, 22, pp. 1254 - 1261, http://dx.doi.org/10.1038/s41436-020-0793-6
,2020, 'Efficacy and safety of D,L-3-hydroxybutyrate (D,L-3-HB) treatment in multiple acyl-CoA dehydrogenase deficiency', Genetics in Medicine, 22, pp. 908 - 916, http://dx.doi.org/10.1038/s41436-019-0739-z
,2020, 'The use of sodium DL-3-Hydroxybutyrate in severe acute neuro-metabolic compromise in patients with inherited ketone body synthetic disorders', Orphanet Journal of Rare Diseases, 15, http://dx.doi.org/10.1186/s13023-020-1316-x
,2020, 'Magnetic resonance imaging pattern recognition in childhood bilateral basal ganglia disorders', Brain Communications, 2, http://dx.doi.org/10.1093/braincomms/fcaa178
,2020, 'Safety and Efficacy of Elosulfase Alfa in Australian Patients with Morquio A Syndrome: A Phase 3b Study', Journal of Inborn Errors of Metabolism and Screening, 8, http://dx.doi.org/10.1590/2326-4594-JIEMS-2020-0001
,2019, 'Mutations in MAGT1 lead to a glycosylation disorder with a variable phenotype', Proceedings of the National Academy of Sciences of the United States of America, 116, pp. 9865 - 9870, http://dx.doi.org/10.1073/pnas.1817815116
,2019, 'International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria', Molecular Genetics and Metabolism, 127, pp. 1 - 11, http://dx.doi.org/10.1016/j.ymgme.2019.04.004
,2018, 'Infantile-onset Pompe disease: A case series highlighting early clinical features, spectrum of disease severity and treatment response', Journal of Paediatrics and Child Health, 54, pp. 1255 - 1261, http://dx.doi.org/10.1111/jpc.14070
,2017, 'Compound heterozygous mutations in glycyl-tRNA synthetase (GARS) cause mitochondrial respiratory chain dysfunction', PLoS ONE, 12, pp. e0178125, http://dx.doi.org/10.1371/journal.pone.0178125
,2017, 'Minimal clinically important difference for the 6-min walk test: Literature review and application to Morquio A syndrome', Orphanet Journal of Rare Diseases, 12, http://dx.doi.org/10.1186/s13023-017-0633-1
,2017, 'Rare case of hepatic gaucheroma in a child on enzyme replacement therapy', , 32, pp. 101 - 104, http://dx.doi.org/10.1007/8904_2016_562
,2016, 'Neurophysiological profile of peripheral neuropathy associated with childhood mitochondrial disease', Mitochondrion, 30, pp. 162 - 167, http://dx.doi.org/10.1016/j.mito.2016.07.014
,2016, 'Clinical course of sly syndrome (mucopolysaccharidosis type VII)', Journal of Medical Genetics, 53, pp. 403 - 418, http://dx.doi.org/10.1136/jmedgenet-2015-103322
,